April 2022

Researchers identify a gene that causes a new neurological and bone syndrome

An international team led by IDIBELL and Necker Hospital in Paris has identified mutations in the SLC35B2 gene as responsible for a syndrome that, although very rare and hitherto unknown, could be affecting hundreds of people around the world who would still remain undiagnosed. Symptoms of this disorder include neurodevelopmental delay, motor dysfunctions, and deformity […]

Researchers identify a gene that causes a new neurological and bone syndrome Read More »

Pharmacological inhibition of a protein reduces metastases in Ewing’s Sarcoma in vivo and in vitro models

The G9a enzyme increases the probability of developing metastases in these bone or soft tissue neoplasms. However, treatment with its inhibitor (BIX01294) could improve the control of metastasis in patients.

Pharmacological inhibition of a protein reduces metastases in Ewing’s Sarcoma in vivo and in vitro models Read More »

Scroll to Top